NFE2L2 and metabolic dysfunction-associated steatotic liver disease: This result is in line with the upregulation of NRF2 expression levels observed in the liver of patients with nonalcoholic fatty liver disease (NAFLD) and diet-induced obesity mouse models, suggesting an involvement of the NRF2/KEAP1 pathway in the regulation of hepatic lipid metabolism [37].